Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

IHT for Mild Cognitive Impairment

NCT: NCT05495087 · RECRUITING

NCT IDNCT05495087
StatusRECRUITING
Start Date2023-02-27
Completion2026-04-30

Brief Summary

This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).

Frequently Asked Questions

What is IHT for Mild Cognitive Impairment?

IHT for Mild Cognitive Impairment is a clinical trial registered under NCT05495087. Current status: RECRUITING.

What is the status of NCT05495087?

The current status of NCT05495087 (IHT for Mild Cognitive Impairment) is: RECRUITING.

When did IHT for Mild Cognitive Impairment start?

IHT for Mild Cognitive Impairment started on 2023-02-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑